Table 1 Using the Kolaskar and Tongaonkar antigenicity approach [57], B-cell epitopes were anticipated with the help of the IEDB B-cell epitope prediction program
Start | End | Peptide | Length | Antigenicity | Allergenicity | Toxicity |
|---|---|---|---|---|---|---|
510 | 515 | WYYLNA | 6 | 1.1522 | Non-allergen | Non-toxin |
282 | 297 | LPSPSLKLGKKVAEAE | 16 | 1.0333 | Non-allergen | Non-toxin |
650 | 656 | WYYLEAS | 7 | 1.0143 | Non-allergen | Non-toxin |
69 | 75 | NKKLQLD | 7 | 0.7865 | Non-allergen | Non-toxin |
109 | 125 | AELPSKIKAKLDAAFDQ | 17 | 0.743 | Non-allergen | Non-toxin |
404 | 414 | EQPQPAPAPQP | 11 | 0.6585 | Non-allergen | Non-toxin |
7 | 38 | ERKVHYSIRKFSVGVAS VVVASLVMGSVVHAT | 32 | 0.6142 | Non-allergen | Non-toxin |
569 | 575 | SWYYLNA | 7 | 0.6079 | Non-allergen | Non-toxin |
549 | 554 | SWYYLN | 6 | 0.5103 | Non-allergen | Non-toxin |
529 | 535 | SWYYLNS | 7 | 0.3833 | Non-allergen | Non-toxin |
663 | 685 | QWFKVSDKWYYVNGLGA LAVNTT | 23 | 0.3554 | Non-allergen | Non-toxin |
97 | 105 | LRELNVLED | 9 | 0.1247 | Non-allergen | Non-toxin |